USPTO serial 79388485
Serial No. 79388485
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jan 7, 2025
- Examiner
- RONCORONI, LAUREN R
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with Serial No. 79388485?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Rebecca Liebowitz
Rebecca Liebowitz Venable LLPP.O. Box 34385Washington, DC 20043United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations and substances for the treatment and prevention of hormonal dysfunction and menopausal symptoms, conditions and disorders; medicinal preparations and substances for the treatment and prevention of hormonal dysfunction and menopausal symptoms, conditions and disorders; medicines for human use for the treatment and prevention of hormonal dysfunction and menopausal symptoms, conditions and disorders; biochemical medicines for human use for the treatment and prevention of hormonal dysfunction and menopausal symptoms, conditions and disorders; pharmaceuticals, namely, pharmaceutical preparations and substances in the field of gynecology and female health for the treatment and prevention of hormonal dysfunction and menopausal symptoms, conditions and disorders; estrogen preparations for therapeutic purposes; pharmaceutical preparations containing estrogen; pharmaceutical preparations for the treatment of female hormonal dysfunction; pharmaceutical preparations for use in hormone replacement therapy; pharmaceutical preparations for the treatment of menopausal symptoms, conditions and disorders | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 26, 2025 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jul 19, 2025 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Jul 9, 2025 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jul 9, 2025 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jul 1, 2025 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jul 1, 2025 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Apr 8, 2025 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jan 7, 2025 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Jan 7, 2025 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Nov 19, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Nov 19, 2024 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Nov 13, 2024 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Oct 10, 2024 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Oct 5, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 5, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 5, 2024 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 11, 2024 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jul 22, 2024 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jul 22, 2024 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jun 27, 2024 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jun 26, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 25, 2024 | DOCK | ASSIGNED TO EXAMINER | — |
| Feb 6, 2024 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Feb 2, 2024 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Feb 1, 2024 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |